DE69714247D1 - Heterozyklische verbindungen - Google Patents

Heterozyklische verbindungen

Info

Publication number
DE69714247D1
DE69714247D1 DE69714247T DE69714247T DE69714247D1 DE 69714247 D1 DE69714247 D1 DE 69714247D1 DE 69714247 T DE69714247 T DE 69714247T DE 69714247 T DE69714247 T DE 69714247T DE 69714247 D1 DE69714247 D1 DE 69714247D1
Authority
DE
Germany
Prior art keywords
pct
sec
date
heterocyclic
connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69714247T
Other languages
English (en)
Other versions
DE69714247T2 (de
Inventor
Leander Merritt
K Reel
L Simon
A Whitesitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69714247D1 publication Critical patent/DE69714247D1/de
Application granted granted Critical
Publication of DE69714247T2 publication Critical patent/DE69714247T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Stereophonic System (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Earth Drilling (AREA)
DE69714247T 1996-04-23 1997-04-23 Heterozyklische verbindungen Expired - Fee Related DE69714247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1600896P 1996-04-23 1996-04-23
PCT/US1997/006699 WO1997040044A1 (en) 1996-04-23 1997-04-23 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
DE69714247D1 true DE69714247D1 (de) 2002-08-29
DE69714247T2 DE69714247T2 (de) 2003-01-23

Family

ID=21774852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714247T Expired - Fee Related DE69714247T2 (de) 1996-04-23 1997-04-23 Heterozyklische verbindungen

Country Status (10)

Country Link
US (1) US6117883A (de)
EP (1) EP0900218B1 (de)
JP (1) JP2000509046A (de)
AT (1) ATE221066T1 (de)
AU (1) AU3055397A (de)
CA (1) CA2250873A1 (de)
DE (1) DE69714247T2 (de)
DK (1) DK0900218T3 (de)
ES (1) ES2180998T3 (de)
WO (1) WO1997040044A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6919447B2 (en) * 2001-06-06 2005-07-19 Weyerhaeuser Company Hypochlorite free method for preparation of stable carboxylated carbohydrate products
US7001483B2 (en) * 2003-08-05 2006-02-21 Weyerhaeuser Company Apparatus for making carboxylated pulp fibers
US20050028953A1 (en) * 2003-08-05 2005-02-10 Severeid David E. Methods for making carboxylated pulp fibers
EP1928437A2 (de) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
AU6010594A (en) * 1993-02-12 1994-08-29 Sankyo Company Limited Isoxazoleoxy derivative
EP0621272B1 (de) * 1993-04-21 1997-11-19 Tosoh Corporation Teilweise als Fungizide verwendbare 3,4-Dioxy-1,2,5-thiadiazole
JPH07188017A (ja) * 1993-09-30 1995-07-25 Souyaku Gijutsu Kenkyusho:Kk チアジアゾール誘導体を含有する抗ウイルス剤
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
WO1997020819A1 (en) * 1995-12-06 1997-06-12 Eli Lilly And Company Composition for treating pain
CA2248153A1 (en) * 1996-03-19 1997-09-25 Novo Nordisk A/S Heterocyclic compounds and their preparation and use

Also Published As

Publication number Publication date
ATE221066T1 (de) 2002-08-15
EP0900218B1 (de) 2002-07-24
EP0900218A4 (de) 2001-05-23
WO1997040044A1 (en) 1997-10-30
ES2180998T3 (es) 2003-02-16
US6117883A (en) 2000-09-12
CA2250873A1 (en) 1997-10-30
JP2000509046A (ja) 2000-07-18
DE69714247T2 (de) 2003-01-23
EP0900218A1 (de) 1999-03-10
AU3055397A (en) 1997-11-12
DK0900218T3 (da) 2002-09-02

Similar Documents

Publication Publication Date Title
ATE219064T1 (de) Piperazinderivative als tachykinin antagonisten
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
EE200000089A (et) Sidesüsteem, mis sisaldab vahendid Interneti aadresside edastamiseks SMS-teenuse abil
ATE201016T1 (de) Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
ATE273956T1 (de) Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
MX9805253A (es) Antagonistas del receptor de vitronectina.
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
DE69734321D1 (de) Non-peptidische vasopressin via antagonisten
AP9901597A0 (en) Vitronectin receptor antagonists.
DE69824433D1 (en) Proteintyrosinphosphatase inhibitoren
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
ES2112546T3 (es) Benz(b)azepina-2,5-dionas utiles en el tratamiento de trastornos neurodegenerativos.
ATE180350T1 (de) Klemmeinrichtung und zugehörige halteeinrichtung
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
DE69714247T2 (de) Heterozyklische verbindungen
AU2001245209A1 (en) Screening methods for bone morphogenetic mimetics
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
BG107046A (en) Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
IT1285777B1 (it) Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
ATE215084T1 (de) Imidazopyridin-azolidinone
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
EP0971885A4 (de) Verfahren zur herstellung von indan-ähnlichen verbindungen
GB2377060A (en) System for ranking financial underwriters
DK0914129T3 (da) Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee